Major Depressive Disorder

>

On the HCPLive Major Depressive Disorder condition center page, resources on the topics of medical news and expert insight into depression can be found. Content includes articles, interviews, videos, podcasts, and breaking news on MDD research, treatment, and drug development.

Latest News

FDA I Image Credit: FDA
Intra-Cellular Therapies Submits sNDA to FDA for Lumateperone as an MDD Adjunctive Therapy

December 3rd 2024

Intra-Cellular Therapies announced they submitted a supplemental New Drug Application to the FDA for lumateperone (CAPLYTA) as an adjunctive therapy to antidepressants for MDD.

SPN-820 Decreases Depressive Symptoms Within Hours of First Dose in Phase 2a Trial
SPN-820 Decreases Depressive Symptoms Within Hours of First Dose in Phase 2a Trial

November 1st 2024

Alto Neuroscience’s ALTO-100 Fails to Beat Placebo in Improving Depressive Symptoms
Alto Neuroscience’s ALTO-100 Fails to Beat Placebo in Improving Depressive Symptoms

October 23rd 2024

FDA Issues CRL for Ketamine to Treat Pain, Mental Health, and More
FDA Issues CRL for Ketamine to Treat Pain, Mental Health, and More

October 23rd 2024

Adding Depression to Cardiovascular Risk Scores Offers Minimal Predictive Benefit
Adding Depression to Cardiovascular Risk Scores Offers Minimal Predictive Benefit

October 21st 2024

More News

© 2024 MJH Life Sciences

All rights reserved.